These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6958 related articles for article (PubMed ID: 18064304)

  • 21. Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production.
    Kim A; Im M; Yim NH; Ma JY
    Sci Rep; 2014 Nov; 4():6994. PubMed ID: 25385232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin.
    Braeuer RR; Zigler M; Kamiya T; Dobroff AS; Huang L; Choi W; McConkey DJ; Shoshan E; Mobley AK; Song R; Raz A; Bar-Eli M
    Cancer Res; 2012 Nov; 72(22):5757-66. PubMed ID: 22986745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oridonin-loaded and GPC1-targeted gold nanoparticles for multimodal imaging and therapy in pancreatic cancer.
    Qiu W; Chen R; Chen X; Zhang H; Song L; Cui W; Zhang J; Ye D; Zhang Y; Wang Z
    Int J Nanomedicine; 2018; 13():6809-6827. PubMed ID: 30425490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
    Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
    Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.
    Claffey KP; Brown LF; del Aguila LF; Tognazzi K; Yeo KT; Manseau EJ; Dvorak HF
    Cancer Res; 1996 Jan; 56(1):172-81. PubMed ID: 8548760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
    Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
    Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice.
    Was H; Cichon T; Smolarczyk R; Rudnicka D; Stopa M; Chevalier C; Leger JJ; Lackowska B; Grochot A; Bojkowska K; Ratajska A; Kieda C; Szala S; Dulak J; Jozkowicz A
    Am J Pathol; 2006 Dec; 169(6):2181-98. PubMed ID: 17148680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TIMP-1 overexpression in pancreatic cancer attenuates tumor growth, decreases implantation and metastasis, and inhibits angiogenesis.
    Bloomston M; Shafii A; Zervos EE; Rosemurgy AS
    J Surg Res; 2002 Jan; 102(1):39-44. PubMed ID: 11792150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation.
    Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y
    J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT.
    Xu D; Yang F; Wu K; Xu X; Zeng K; An Y; Xu F; Xun J; Lv X; Zhang X; Yang X; Xu L
    Cancer Biol Ther; 2020 Apr; 21(4):354-363. PubMed ID: 31906774
    [No Abstract]   [Full Text] [Related]  

  • 32. RSUME is implicated in tumorigenesis and metastasis of pancreatic neuroendocrine tumors.
    Wu Y; Tedesco L; Lucia K; Schlitter AM; Garcia JM; Esposito I; Auernhammer CJ; Theodoropoulou M; Arzt E; Renner U; Stalla GK
    Oncotarget; 2016 Sep; 7(36):57878-57893. PubMed ID: 27506944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
    Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
    Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis.
    Küsters B; Kats G; Roodink I; Verrijp K; Wesseling P; Ruiter DJ; de Waal RM; Leenders WP
    Oncogene; 2007 Aug; 26(39):5808-15. PubMed ID: 17353901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin.
    Czubayko F; Schulte AM; Berchem GJ; Wellstein A
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14753-8. PubMed ID: 8962127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-angiogenic and anti-metastatic effects of beta-1,3-D-glucan purified from Hanabiratake, Sparassis crispa.
    Yamamoto K; Kimura T; Sugitachi A; Matsuura N
    Biol Pharm Bull; 2009 Feb; 32(2):259-63. PubMed ID: 19182386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syndecan-1 is required for robust growth, vascularization, and metastasis of myeloma tumors in vivo.
    Khotskaya YB; Dai Y; Ritchie JP; MacLeod V; Yang Y; Zinn K; Sanderson RD
    J Biol Chem; 2009 Sep; 284(38):26085-95. PubMed ID: 19596856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Li J; Chen Y; Zhan C; Zhu J; Weng S; Dong L; Liu T; Shen X
    Dig Dis Sci; 2019 Jun; 64(6):1493-1502. PubMed ID: 30730015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
    Bockhorn M; Tsuzuki Y; Xu L; Frilling A; Broelsch CE; Fukumura D
    Clin Cancer Res; 2003 Sep; 9(11):4221-6. PubMed ID: 14519649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 348.